Amitifadine, a triple monoamine uptake inhibitor reduces binge drinking and negative affect in an animal model of co-occurring alcoholism and depression symptomatology

Por Warnock, Kaitlin T., Yang, Andrew R.S.T., Yi, Heon S., June, Harry L., Kelly, Tim, Basile, Anthony S., Skolnick, Phil, June, Harry L.
Publicado em 2012

Binge alcohol drinking is associated with GABA(A) α2-regulated Toll-like receptor 4 (TLR4) expression in the central amygdala

Por Liu, Juan, Yang, Andrew R., Kelly, Timothy, Puche, Adam, Esoga, Chioma, June, Harry L., Elnabawi, Ahmed, Merchenthaler, Istvan, Sieghart, Werner, June, Harry L., Aurelian, Laure
Publicado em 2011

Binge Drinking: In Search of its Molecular Target via the GABA(A) Receptor

Por Yang, Andrew R. S. T., Liu, Juan, Yi, Heon S., Warnock, Kaitlin T., Wang, Mingfei, June, Harry L., Puche, Adam C., Elnabawi, Ahmed, Sieghart, Werner, Aurelian, Laure, June, Harry L.
Publicado em 2011

Effects of the Triple Monoamine Uptake Inhibitor DOV 102,677 on Alcohol-Motivated Responding and Antidepressant Activity in Alcohol-Preferring (P) Rats

Por Yang, Andrew R.S.T., Yi, Heon Soo, Warnock, Kaitlin T., Mamczarz, Jacek, June, Harry L., Mallick, Nikhil, Krieter, Philip A., Tonelli, Leonardo, Skolnick, Phil, Basile, Anthony S., June, Harry L.
Publicado em 2011